Equaline Heartburn Relief
Loading...Equaline Heartburn Relief Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers
- if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
- with other acid reducers
- frequent chest pain
- frequent wheezing, particularly with heartburn
- unexplained weight loss
- nausea or vomiting
- stomach pain
- had heartburn over 3 months. This may be a sign of a more serious condition
- heartburn with lightheadedness, sweating or dizziness
- chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
- your heartburn continues or worsens
- you need to take this product for more than 14 days
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
- if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
- with other acid reducers
- frequent chest pain
- frequent wheezing, particularly with heartburn
- unexplained weight loss
- nausea or vomiting
- stomach pain
- had heartburn over 3 months. This may be a sign of a more serious condition
- heartburn with lightheadedness, sweating or dizziness
- chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
- your heartburn continues or worsens
- you need to take this product for more than 14 days
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
- relieves heartburn associated with acid indigestion and sour stomach
- prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Equaline Heartburn Relief Manufacturers
-
Supervalu Inc
![Equaline Heartburn Relief (Ranitidine) Tablet [Supervalu Inc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Equaline Heartburn Relief | Supervalu Inc
adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily (do not take more than 2 tablets in 24 hours) children under 12 years: ask a doctor -
Supervalu Inc
Equaline Heartburn Relief | Mylan Pharmaceuticals Inc.
2.1 General Dosing Recommendations • Ropinirole extended-release tablets are taken once daily, with or without food [see Clinical Pharmacology (12.3)]. • Tablets must be swallowed whole and must not be chewed, crushed, or divided. • If a significant interruption in therapy with ropinirole extended-release tablets has occurred, retitration of therapy may be warranted. 2.2 Dosing for Parkinson’s DiseaseThe starting dose is 2 mg taken once daily for 1 to 2 weeks, followed by increases of 2 mg/day at one week or longer intervals as appropriate, based on therapeutic response and tolerability. The maximum recommended dose of ropinirole extended-release tablets is 24 mg/day.
In clinical trials, dosage was initiated at 2 mg/day and gradually titrated based on individual patient therapeutic response and tolerability. Doses greater than 24 mg/day have not been studied in clinical trials. Patients should be assessed for therapeutic response and tolerability at a minimal interval of one week or longer after each dose increment. Monitor patients during dose titration because too rapid a rate of titration may lead to dose selection that may not provide additional benefit, but that may increase the risk of adverse reactions [see Clinical Studies (14.2)]. Due to the flexible dosing design used in clinical trials, specific dose-response information could not be determined.
Ropinirole extended-release tablets should be discontinued gradually over a 7-day period.
Renal ImpairmentNo dose adjustment is necessary in patients with moderate renal impairment (creatinine clearance of 30 to 50 mL/min). The recommended initial dose of ropinirole extended-release tablets for patients with end-stage renal disease on hemodialysis is 2 mg once daily. Further dose escalations should be based on tolerability and need for efficacy. The recommended maximum total daily dose is 18 mg/day in patients receiving regular dialysis. Supplemental doses after dialysis are not required. The use of ropinirole extended-release tablets in patients with severe renal impairment without regular dialysis has not been studied.
2.3 Switching from Immediate-release Ropinirole Tablets to Ropinirole Extended-release TabletsPatients may be switched directly from immediate-release ropinirole to ropinirole extended-release tablets. The initial dose of ropinirole extended-release tablets should most closely match the total daily dose of the immediate-release formulation of ropinirole, as shown in Table 1.
Table 1: Conversion from Immediate-release Ropinirole to Extended-release RopiniroleImmediate-release Ropinirole
Tablets
Total Daily Dose (mg)
Ropinirole
Extended-release Tablets
Total Daily Dose (mg)
0.75 to 2.25
2
3 to 4.5
4
6
6
7.5 to 9
8
12
12
15
16
18
18
21
20
24
24
Following conversion to ropinirole extended-release tablets, the dose may be adjusted depending on therapeutic response and tolerability [see Dosage and Administration (2.2)].
2.4 Effect of Gastrointestinal Transit Time on Medication ReleaseRopinirole extended-release tablets are designed to release medication over a 24-hour period. If rapid gastrointestinal transit occurs, there may be risk of incomplete release of medication and medication residue being passed in the stool.
![Equaline Heartburn Relief (Ranitidine) Tablet, Film Coated [Supervalu Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a5dd30b1-26b1-4463-9da0-b55af901d222&name=image-02.jpg)
Login To Your Free Account